July 23, 2026
VERAXA Biotech Receives Regulatory Support from Germany’s Paul-Ehrlich-Institute for BiTAC®-TCE Platform
July 23, 2026
Recent Disease Outbreaks Expose Critical Gaps in U.S. Public Health Systems, Expert Says
July 23, 2026
Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Treatment Methods
July 23, 2026
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Lead BiTAC Platform Development
July 22, 2026
Kairos Pharma Collaborates with Bayer to Test ENV-105 in Combination with Xofigo for Advanced Prostate Cancer
July 22, 2026
VERAXA Biotech Receives Positive Regulatory Guidance for BiTAC-TCE Platform from German Authority
July 21, 2026
Greenwich LifeSciences Advances Phase 3 Breast Cancer Immunotherapy Trial with Expanded Enrollment
July 21, 2026
Quantum BioPharma Targets Multiple Sclerosis and Alcohol Intoxication with Novel Pipeline
July 21, 2026
Michael Svestka, MD, FACS, Named 2026 Castle Connolly Top Doctor for Hernia Surgery Expertise
July 20, 2026
World Brain Day Highlights New Initiative to Translate Brain Health Research into Daily Habits
July 20, 2026
VERAXA Biotech Receives Regulatory Feedback Advancing BiTAC-TCE Cancer Therapy Toward Clinical Development
July 18, 2026
Cayenne Wellness Center Unveils ‘Scar Stories’ Art Exhibit Highlighting Sickle Cell Warriors
July 17, 2026
No Agenda Episode 1886 Examines Cyclospora Outbreak, Lindsey Graham Autopsy, and Media Narratives
